Search
The production of functional antipneumococcal antibodies in otitisprone children demonstrates that they respond to the current pneumococcal conjugate vaccine (PCV)and are likely to respond to pneumolysin-based vaccines as effectively as healthy children.
A single dose of rubella vaccine will take longer to reduce the burden of rubella and will be less robust to lower vaccine coverage
This study provides a quantitative estimate of the total burden of invasive pneumococcal disease preventable by vaccination programs in Australia
The aim of this study was to describe the characteristics of patients with multidrug-resistant tuberculosis and to investigate risk factors
This study will assess the effect of adjunctive clindamycin on patient-centred outcomes in severe, toxin-mediated S. aureus infections
Large variation in antibiotic prescribing amongst clinicians is demonstrated and increased, corresponding with escalating case complexity and persisting MRSA bacteraemia
One dose of MenACWY-TT boosts protection against MenC in primed children, is safe and extends protection against MenA, MenW and MenY
We identified the existence of more than 290 clinically associated genomic phylogroups across 22 countries, highlighting challenges in designing vaccines of global utility
Overall, the 2016 influenza vaccine showed good protection against laboratory-confirmed infection among general practice patients
This large population-based study suggests a significant healthcare burden associated with influenza in children with a range of chronic lung diseases